rdf:type |
|
lifeskim:mentions |
umls-concept:C0001721,
umls-concept:C0017262,
umls-concept:C0024432,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0678594,
umls-concept:C0752312,
umls-concept:C0851285,
umls-concept:C0887870,
umls-concept:C1332794,
umls-concept:C1515568,
umls-concept:C1704657,
umls-concept:C1704711,
umls-concept:C1879547,
umls-concept:C2911684
|
pubmed:issue |
2
|
pubmed:dateCreated |
1999-3-15
|
pubmed:abstractText |
The protein tyrosine kinase pp125FAK (focal adhesion kinase, or FAK) is expressed by a variety of cell types and has been implicated in integrin-mediated signaling events. We explored the potential functions of FAK by expressing it de novo in a cell type lacking FAK. We showed previously that cultured human macrophages lack FAK yet still have well-formed focal contacts. Adenovirus-mediated expression of FAK results in the appearance of FAK protein, which localizes to focal contacts and becomes tyrosine-phosphorylated without perturbing overall cell morphology or focal contacts. FAK associates with CSK 48 h after infection and recruits it to focal contacts. Tyrosine phosphorylation of p130cas but not of paxillin is stimulated after FAK expression. The phosphorylation of p130cas is lost at 48 h in parallel with CSK accumulation in focal contacts. The ERK2 form of MAP kinase is similarly activated at 12-24 h, but it also returns to low levels at 48 h. These findings demonstrate that FAK can be reconstituted to focal contacts in cells that lack it without affecting cell morphology or focal contact structure. FAK can regulate the distribution and activities of elements of the MAP kinase signaling pathway.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-9541
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
178
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
164-72
|
pubmed:dateRevised |
2011-11-2
|
pubmed:meshHeading |
pubmed-meshheading:10048580-Adenoviruses, Human,
pubmed-meshheading:10048580-Calcium-Calmodulin-Dependent Protein Kinases,
pubmed-meshheading:10048580-Cell Adhesion,
pubmed-meshheading:10048580-Cell Adhesion Molecules,
pubmed-meshheading:10048580-Enzyme Activation,
pubmed-meshheading:10048580-Focal Adhesion Kinase 1,
pubmed-meshheading:10048580-Focal Adhesion Protein-Tyrosine Kinases,
pubmed-meshheading:10048580-Gene Expression,
pubmed-meshheading:10048580-Gene Transfer Techniques,
pubmed-meshheading:10048580-Humans,
pubmed-meshheading:10048580-Macrophages,
pubmed-meshheading:10048580-Phosphorylation,
pubmed-meshheading:10048580-Protein-Tyrosine Kinases,
pubmed-meshheading:10048580-Tyrosine,
pubmed-meshheading:10048580-src-Family Kinases
|
pubmed:year |
1999
|
pubmed:articleTitle |
De novo expression of pp125FAK in human macrophages regulates CSK distribution and MAP kinase activation but does not affect focal contact structure.
|
pubmed:affiliation |
Craniofacial Developmental Biology and Regeneration Branch, NIDCR, NIH, Bethesda, Maryland 20892-4370, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro
|